Skip to content
Menu

Voyager Therapeutics, Inc. VYGR

Full chart Compare
Set alert

Price alert · VYGR

All alert types
1.53 USD -0.08 (-4.97%)

Regular-session close

1.53 0.00 0.00%

After hours · Nov 20, 4:01 PM ET

1.51 Day range 1.65
1.52 52-week range 5.00
YTD
-61.07%
1 year
-62.59%

Revenue & Expenses

Revenue Profit Costs
Other Income$12.27MOther Operating Income$131.17MNet Loss$119.72MCost of Revenue$132.27MExpenses$263.16MGross Loss$91.90MSelling, General & Admin$36.44MResearch & Development$134.67MIncome Tax$144.00KRevenue$40.37M

Latest period ending Dec 31, 2025 · select a line to chart its full history

VYGR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
40.37M80.00M250.01M40.91M37.41M
40.37M80.00M250.01M40.91M37.41M
-131.84M-83.29M122.01M-50.84M-73.62M
-119.72M-65.00M132.33M-46.41M-71.20M
-2.04-1.132.97-1.21-1.89
VYGR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
68.04M74.24M70.39M98.96M117.43M
252.28M393.05M351.28M159.36M193.85M
56.20M93.29M114.96M100.34M98.80M
36.50M43.73M20.29M00
196.08M299.76M236.32M59.02M95.06M
VYGR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-132.47M-15.31M77.92M-12.51M-53.52M
125.45M-94.86M-141.64M-7.34M65.91M
816.00K114.02M33.65M1.11M612.00K
-2.60M-3.52M-3.26M-2.49M-1.61M
-6.21M3.85M-30.08M-18.74M12.99M